Skip to main content
رجوع
GRDN logo

Guardian Pharmacy Services, Inc.

جودة البيانات: 100%
ذروة شراء
GRDN
NYSE Healthcare Medical - Distribution
KWD 37.26
▲ KWD 1.64 (4.60%)
القيمة السوقية: 2.36B
نطاق اليوم
KWD 36.00 KWD 38.09
نطاق 52 أسبوعًا
KWD 19.17 KWD 38.09
حجم التداول
617,407
متوسط 50 يوم / 200 يوم
KWD 32.28 / KWD 27.21
الإغلاق السابق
KWD 35.62

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 48.0 0.4
P/B 11.5 2.9
ROE % 28.3 3.8
Net Margin % 3.4 3.9
Rev Growth 5Y % 16.3 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 36.000 -3.4%
Low: KWD 30.000 High: KWD 40.000
مكرر الربحية المستقبلي
30.2
ربحية السهم المستقبلية
KWD 1.235
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.4 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2028 KWD 1.460
KWD 1.443 – KWD 1.477
1.7 B 2
FY2027 KWD 1.358
KWD 1.308 – KWD 1.397
1.5 B 3
FY2026 KWD 1.235
KWD 1.205 – KWD 1.255
1.4 B 3

النقاط الرئيسية

Revenue grew 16.29% annually over 5 years — strong growth
ROE of 28.25% indicates high profitability
Debt/Equity of 0.22 — conservative balance sheet
Generating 80.71M in free cash flow
P/E of 47.95 — premium valuation
Cash machine — converts 163.98% of earnings into free cash flow

النمو

Revenue Growth (5Y)
16.29%
Revenue (1Y)17.93%
Earnings (1Y)N/A
FCF Growth (3Y)19.77%

الجودة

Return on Equity
28.25%
ROIC26.62%
Net Margin3.40%
Op. Margin6.14%

الأمان

Debt / Equity
0.22
Current Ratio1.38
Interest Coverage133.71

التقييم

P/E Ratio
47.95
P/B Ratio11.47
EV/EBITDA26.31
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 17.93% Revenue Growth (3Y) 17.67%
Earnings Growth (1Y) N/A Earnings Growth (3Y) 43.50%
Revenue Growth (5Y) 16.29% Earnings Growth (5Y) 31.79%
Profitability
Revenue (TTM) 1.45B Net Income (TTM) 49.22M
ROE 28.25% ROA 11.93%
Gross Margin 19.47% Operating Margin 6.14%
Net Margin 3.40% Free Cash Flow (TTM) 80.71M
ROIC 26.62% FCF Growth (3Y) 19.77%
Safety
Debt / Equity 0.22 Current Ratio 1.38
Interest Coverage 133.71 Dividend Yield 0.00%
Valuation
P/E Ratio 47.95 P/B Ratio 11.47
P/S Ratio 1.63 PEG Ratio -0.26
EV/EBITDA 26.31 Dividend Yield 0.00%
Market Cap 2.36B Enterprise Value 2.34B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.45B 1.23B 1.05B 908.91M 792.07M
Net Income 49.22M -87.29M 23.90M 35.42M 16.31M
EPS (Diluted) 0.78 -1.77 0.39 0.58 0.27
Gross Profit 282.04M 244.37M 208.31M 185.87M 161.27M
Operating Income 88.91M -62.92M 40.95M 51.99M 30.15M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 412.66M 320.81M 271.17M 256.11M 235.85M
Total Liabilities 194.73M 170.83M 211.31M 180.18M 182.53M
Shareholders' Equity 205.76M 142.67M 28.21M 42.73M 23.93M
Total Debt 44.72M 37.33M 69.15M 62.98M 55.04M
Cash & Equivalents 65.62M 4.66M 752,000.0 607,000.0 15.01M
Current Assets 221.63M 151.99M 129.60M 120.00M 111.87M
Current Liabilities 160.70M 144.12M 138.02M 112.01M 111.54M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#836 of 1024
29

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026